Diagnostics
As the understanding of the molecular basis of disease grows, so will the availability of novel tests that will offer disease screening, guide therapy selection, and characterize the variability of therapy response in individual patients.
Boston Healthcare broadly supports its IVD clients in the development of comprehensive regulatory and commercialization
strategies for novel technologies that drive the real value proposition for diagnostics—patients get optimal treatment
while ineffective care and related expenses can be reduced.
View Diagnostic Case Studies